Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | CDK4 | P11802 | 5/20 | 0.80 |
| ▸ | CCND1 | P24385 | 5/20 | 0.80 |
| ▸ | NPC1 | O15118 | 3/20 | 0.75 |
| ▸ | RAB9A | P51151 | 3/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | GLA | P06280 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.69 |
| ▸ | SIRT1 | Q96EB6 | 5/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicotredole SCHEMBL29454469 | 1.00 | MEN1 (1.00) | MEN1KMT2ACDK4CCND1NPC1 | |
| Nicotredole SCHEMBL17824507 | 0.90 | MEN1 (0.81) | MEN1KMT2ACDK4CCND1NPC1 | |
| SCHEMBL13942359 | 0.88 | CDK4 (0.83) | MEN1KMT2ACDK4CCND1NPC1 | |
| SCHEMBL7960829 | 0.87 | MEN1 (0.78) | MEN1KMT2ACDK4CCND1NPC1 | |
| Behenic Acid SCHEMBL4075758 | 0.87 | MEN1 (0.76) | MEN1KMT2ACDK4CCND1NPC1 | |
| SCHEMBL25253674 | 0.86 | HPGD (0.79) | MEN1KMT2ACDK4CCND1NPC1 | |
| SCHEMBL4331421 | 0.86 | MEN1 (1.00) | MEN1KMT2ACDK4CCND1NPC1 | |
| SCHEMBL23470288 | 0.86 | MEN1 (0.75) | MEN1KMT2ACDK4CCND1NPC1 | |
| Nicotredole SCHEMBL2544181 | 0.85 | MEN1 (0.72) | MEN1KMT2ACDK4CCND1NPC1 | |
| Cyanide SCHEMBL31484737 | 0.83 | MEN1 (0.92) | MEN1KMT2ACDK4CCND1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132327-A1 | USE OF QUORUM QUENCHING (QQ) COMPOUNDS FOR AVOIDING THE FORMATION OF BIOFILMS, BIOFOULING OR BIOCORROSION ON SURFACES | Johannes Gutenberg-Universität Mainz (DE) | 2025-06-26 | — | — | WO | claimed |
| CN-117137048-A | Flavor composition, food comprising the same, and method for increasing the flavor intensity of the umami taste of food | 马斯公司 | 2023-12-01 | — | — | CN | claimed |
| CN-114181944-A | Mutant gene and use thereof | 中国科学院动物研究所 | 2022-03-15 | — | — | CN | claimed |
| EP-3207029-B1 | TRYPTAMIDE COMPOSITIONS AND METHODS OF USE | SIGNUM BIOSCIENCES INC (US) | 2021-08-04 | — | — | EP | claimed |
| CN-107108495-B | Chromate compositions and methods of use | 希格诺生物科学有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-105198786-A | Aryl-substituted amide compound, preparing method thereof, medicine composition comprising same, and application thereof | INST MED BIOTECHNOLOGY CAMS | 2015-12-30 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| US-7417027-B2 | Linear and cyclic melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2008-08-26 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1441750-A4 | LINEAR AND CYCLIC MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | PALATIN TECHNOLOGIES INC (US) | 2006-10-18 | — | — | EP | claimed |
| US-20050038230-A1 | Linear and cyclic melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2005-02-17 | — | — | US | claimed |
| EP-1441750-A2 | LINEAR AND CYCLIC MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | Palatin Technologies, Inc. (US) | 2004-08-04 | — | — | EP | claimed |
| WO-2003006620-A2 | LINEAR AND CYCLIC MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | PALATIN TECHNOLOGIES, INC. (US) | 2003-01-23 | — | — | WO | claimed |
| EP-0770091-B1 | COMPOUNDS FOR REVERSING DRUG RESISTANCE | SARKADI BALAZS (HU) | 2000-03-01 | — | — | EP | claimed |
| EP-0770091-A1 | COMPOUNDS FOR REVERSING DRUG RESISTANCE | Sarkadi, Balazs (HU) | 1997-05-02 | — | — | EP | claimed |
| WO-1995031474-A1 | COMPOUNDS FOR REVERSING DRUG RESISTANCE | SARKADI BALAZS (HU) | 1995-11-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038230-A1 | Linear and cyclic melanocortin receptor-specific peptides | MC1R, MC3R, MC5R | MEN1 582/4885KMT2A 1546/4885CDK4 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.